Glucon
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Glucon - overview
Location
Boulder, CO, US
Primary Industry
Medical Devices & Equipment
About
Glucon is a technology firm focused on developing innovative solutions to enhance digital connectivity and efficiency for businesses worldwide. Their products are designed to streamline operations and improve client engagement across various sectors. Glucon specializes in delivering cutting-edge technology solutions that optimize digital operations. The company was founded in Boulder, US, and has undergone significant strategic pivots to adapt to market demands.
It has successfully raised a total of USD 13. 00 mn through its latest Series C funding round led by Giza Venture Capital, with participation from Infinity Venture. The firm has previously closed deals including two significant rounds up to February 2007, marking its growth trajectory. The founder's background includes experience in technology entrepreneurship, contributing to Glucon's innovative direction.
Glucon offers a range of technology services aimed at enhancing digital infrastructure for businesses. Their core products include advanced software solutions that facilitate improved client interactions and operational efficiencies. The company also provides consulting services to tailor solutions for specific business needs, supporting a variety of industries such as finance, healthcare, and e-commerce. Glucon generates revenue through the sale of its software solutions and consulting services, targeting both corporate clients and small businesses.
The company's revenue model includes direct sales of software licenses and service subscriptions, ensuring a steady cash flow generated from its diverse product offerings. Glucon plans to introduce several new software products aimed at expanding their service offerings, with launches expected in the coming year. The company is targeting expansion into the European and Asian markets by the end of 2024, seeking to establish a strong presence in these regions. Recent funding from the Series C round will be utilized to develop these new products and support their market entry strategies.
Current Investors
Infinity Venture, Giza Venture Capital, 3i
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment
Website
www.glucon.com
Verticals
FinTech
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.